His career has included stops at Eli Lilly, Novian Health and, for the last 16 years, Amgen. His tenure at Amgen included roles in sales and marketing for many of its hematology and oncology ...

In a report released today, Srikripa Devarakonda from Truist Financial assigned a Hold rating to Amgen (AMGN – Research Report). The company’s shares closed yesterday at $267.10. Discover ...

Analyst Evan Seigerman of BMO Capital maintained a Buy rating on Amgen (AMGN – Research Report), retaining the price target of $362.00. Discover outperforming stocks and invest smarter with Top ...

the company later explained that OpenELM was an open-source model created for research purposes and that its database is not used to power Apple Intelligence. According to Apple, its AI features ...

THOUSAND OAKS, Calif., Jan. 8, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2025 J.P. Morgan Healthcare Conference at 3:00 p.m. PT on Monday, January ...

New Stocks in F&O Segment The National Stock Exchange has added six more stocks - Castrol India, Gland Pharma, NBCC (India), Phoenix Mills, Solar Industries India, and Torrent Power - to the F&O ...